Impact Factor
2.83
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.12
120 total citations
h5-index
15
h5 depth signal
Cited share
68.4%
39 of 57
Total citations
120
Citation footprint
Metric signal
1.35
External metric anchor
Self-citation
0.8%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
104
China
75
United States
69
United Kingdom
24
South Korea
21
Citing Fields of Research
Pharmacology & Toxicology
190
Cancer Drugs
99
Drug Delivery Systems
60
Cellular Membrane Transporters & Receptors
51
Molecular & Cellular Toxicology
20
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,577
Articles tracked across the journal lifetime
Indexed publication set
57
39 cited publications
Last 12 months
23
3.3 publications/month
Open access share
21.7%
5 OA publications in the last year
Leading citing country
Japan
104 citing publications
Leading citing field
Pharmacology & Toxicology
190 citing publications
Latest tracked publication
20 June 2026
10 recent records available
Coverage & Indexing History
v1n1, 1979-
v1n1, 1979-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Pharmacology & Toxicology
Cancer Drugs
Cellular Membrane Transporters & Receptors
Kidney Diseases
Broad Categories
Pharmacology
Drug Delivery Systems
Pharmacology & Toxicology
Cancer Drugs
Physiology
Transplantation
MeSH Descriptors
Biopharmaceutics
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/bdd.70035
Open DOI
Prediction of Human Serum Concentration–Time Profiles of Golimumab and Ustekinumab Using Pharmacokinetic Data From Common Marmosets With Assessment of Anti‐Drug Antibodies
In a previous study, retrospective predictions of human serum concentration–time profiles for three therapeutic monoclonal antibodies (mAbs) with linear pharmacokinetics were performed using allometric scaling in common marmosets and ach...
02
DOI 10.1002/bdd.70032
Open DOI
Optimized GFR Estimation Equations for Chinese Neonates and Children: Development of New Models and Comparison With Existing Ones
Glomerular filtration rate (GFR) maturation is critical for drug dosing in neonates and children. Current equations face dual limitations: they are primarily derived from Caucasian populations and fail to account for the fundamental phys...
03
DOI 10.1002/bdd.70038
Open DOI
Issue Information
04
DOI 10.1002/bdd.70037
Open DOI
Tebapivat: Pharmacokinetic Properties in Preclinical Species and Pharmacodynamic Responses Associated With Pyruvate Kinase Activation in Wild‐Type Mice
The investigation of pyruvate kinase activating drugs is expanding into previously untested diseases as the benefits of increasing glycolytic flux within pyruvate kinase‐expressing tissues emerges. Recently, we reported the discovery of ...
05
DOI 10.1002/bdd.70036
Open DOI
Development of a Biorelevant In Vitro Release System and Level A In Vitro‐In Vivo Correlation for Doxorubicin Hydrochloride Liposome Injection via Flow‐Through Cell Method
Doxorubicin hydrochloride liposome injection represents a complex nano‐drug delivery system with significant clinical advantages, yet its quality evaluation remains challenging. Traditional static release methods often fail to simulate t...
06
DOI 10.1002/bdd.70034
Open DOI
Pharmacokinetic Assessment of Atazanavir and Favipiravir Following Echinacea Supplementation: A Controlled Herb–Drug Interaction Investigation
Echinacea is a widely used herbal supplement and is frequently co‐administered with antiviral drugs, raising concerns regarding potential herb–drug interactions. This study evaluated the effect of repeated Echinacea administration on the...
07
DOI 10.1002/bdd.70033
Open DOI
A Slowly Self‐Emulsifying Delivery System of Sesamin With Improved Biopharmaceutical Properties
This study is the first attempt to develop a novel slowly self‐emulsifying drug delivery system (SL‐SEDDS) of sesamin (SES) for improved biopharmaceutical properties. Firstly, SES‐loaded self‐emulsifying drug delivery system (SEDDS/SES) ...
08
DOI 10.1002/bdd.70029
Open DOI
Ointment for Topical Ocular Delivery of Voriconazole: Formulation Development, In‐Vitro Characterization & In‐Vivo Pharmacokinetic Assessment
Voriconazole (VCZ) is a broad‐spectrum antifungal agent widely used for treating fungal infections caused by Candida , Aspergillus , and Fusarium species, which are commonly associated with fungal keratitis (FK). Topical ophthalmic ointm...
09
DOI 10.1002/bdd.70028
Open DOI
Corneal Targeted Mucoadhesive Emulsion for Prolonged Delivery of Voriconazole: Formulation Evaluation and Pharmacokinetic Assessment
Voriconazole, a broad‐spectrum triazole antifungal, is widely prescribed for fungal keratitis (FK) caused by Candida , Aspergillus , and Fusarium species. Conventional ophthalmic solutions are limited by rapid clearance and low bioavaila...
10
DOI 10.1002/bdd.70030
Open DOI
A Novel Slowly Self‐Emulsifying Drug Delivery System: Prolonged Systemic Exposure of Tacrolimus With Reduced Risks of Systemic Side Effects
This study aimed to design and characterize a new type of self‐emulsifying drug delivery system (SEDDS), slowly SEDDS (SL‐SEDDS), for long‐lasting systemic exposure of tacrolimus (TAC) with reduced nephrotoxicity. TAC‐loaded SL‐SEDDS (SL...
Bibliographical & Catalog Notes
Also issued online.
Vol. 7, no. 1 (JAN 1986)19900918 Notice published Printed on acid-free paper